Company Valuation: Transgene

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 247.8 164.8 137.8 89.75 262.9 198 - -
Change - -33.52% -16.38% -34.86% 192.89% -24.67% - -
Enterprise Value (EV) 1 214.9 151.4 139.4 83.48 153.1 128.8 190.3 216.6
Change - -29.53% -7.95% -40.12% 83.37% -15.85% 47.74% 13.82%
P/E -12.1x -5.02x -6.23x -2.34x -3.69x -5.16x -3.29x -8.03x
PBR 3.69x 4.38x 8.82x 5.92x 1.14x 2.41x 9.04x -72.3x
PEG - -0.1x 0.2x -0.1x 0.4x 0.1x -0.1x 0.1x
Capitalization / Revenue 14.2x 15.9x 17.4x 14.1x 36.5x 27.5x 27.5x 3.46x
EV / Revenue 12.3x 14.6x 17.6x 13.1x 21.2x 17.9x 26.4x 3.79x
EV / EBITDA -10.2x -5.37x -4.9x -2.43x -4.54x -2.95x -2.71x -9.18x
EV / EBIT -9.14x -5.06x -4.64x -2.34x -4.37x -2.91x -2.69x -7.39x
EV / FCF -6.59x -6.94x -1,408x -3.12x -1.07x -3.24x -3.15x -8.63x
FCF Yield -15.2% -14.4% -0.07% -32% -93.4% -30.8% -31.7% -11.6%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.21 -0.33 -0.22 -0.29 -0.26 -0.14 -0.22 -0.09
Distribution rate - - - - - - - -
Net sales 1 17.41 10.34 7.9 6.353 7.21 7.2 7.2 57.2
EBITDA 1 -21 -28.22 -28.48 -34.38 -33.73 -43.6 -70.1 -23.6
EBIT 1 -23.52 -29.9 -30.05 -35.66 -35.06 -44.3 -70.8 -29.3
Net income 1 -19.54 -32.8 -22.33 -33.97 -37.52 -38.2 -61.6 -25.3
Net Debt 1 -32.93 -13.31 1.629 -6.274 -109.8 -69.2 -7.7 18.6
Reference price 2 2.5400 1.6580 1.3700 0.6800 0.9600 0.7230 0.7230 0.7230
Nbr of stocks (in thousands) 97,576 99,370 100,566 131,990 273,827 273,882 - -
Announcement Date 16/03/22 16/03/23 27/03/24 27/03/25 24/03/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-5.16x17.89x-2.95x - 225M
21.08x6.49x14.2x1.51% 55.92B
33.57x8.33x25.41x0.06% 56.67B
-18.45x4.44x-7.77x-.--% 23.28B
-42.05x13.36x-39.35x-.--% 23.28B
25.7x5.07x13.38x-.--% 20.54B
24.87x4.83x15.68x-.--% 17.78B
-617.89x37.85x-1571.42x-.--% 15.9B
44.16x17.85x45.97x0.08% 14.64B
17.51x5.07x11.83x-.--% 13.99B
Average -51.67x 12.12x -149.50x 0.18% 24.22B
Weighted average by Cap. -25.97x 9.81x -92.70x 0.37%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA